摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1H-茚-2-硼酸 | 312968-21-1

中文名称
1H-茚-2-硼酸
中文别名
——
英文名称
2-indenylboronic acid
英文别名
2-indeneboronic acid;indene-2-boronic acid;(1H-inden-2-yl)boronic acid;1H-indene-2-boronic acid;1H-inden-2-ylboronic acid
1H-茚-2-硼酸化学式
CAS
312968-21-1
化学式
C9H9BO2
mdl
MFCD11506071
分子量
159.98
InChiKey
VBMIZCKXRRAXBK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    57-77°C

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2931900090
  • 危险性防范说明:
    P264,P280,P302+P352,P337+P313,P305+P351+P338,P362+P364,P332+P313
  • 危险性描述:
    H315,H319

SDS

SDS:530b623e388d4c13dc0569d756fa18f3
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 1H-Indene-2-boronic acid
CAS-No. : 312968-21-1
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
This substance is not classified as dangerous according to Directive 67/548/EEC.
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C9H9BO2
Molecular Weight : 161,99 g/mol

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Borane/boron oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: 2 - 8 °C
Handle under nitrogen, protect from moisture. Store under nitrogen.
Specific end use(s)
no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 57 - 77 °C
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation
May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine Pollutant: no IATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    1H-茚-2-硼酸 在 bis-triphenylphosphine-palladium(II) chloride sodium carbonate 、 三乙胺亚硝酸异戊酯 作用下, 以 1,4-二氧六环乙醇1,2-二氯乙烷甲苯 为溶剂, 反应 30.5h, 生成 1,2,3,4-二苯并芴
    参考文献:
    名称:
    加入环:2-和3-茚基-三萜烯的制备,以及与之相关的好奇过程。
    摘要:
    茚基三萜烯和3-茚基或3-茚基分别连接在三萜烯的9位上,是分子齿轮系统的诱人原型,也可以集成制动器。这些分子是由它们各自的茚基蒽制成的,并且是通过[4 + 2]苯并环与蒽片段的环加成反应以及在(12 kcal mol(-1))和( <9 kcal mol(-1))已被测量。通过使用钯催化的偶联反应制备前体蒽和。出乎意料的是,9-溴蒽与茚的Heck型反应导致3-茚基蒽的形成。此外,该过程伴随有新颖的钯催化的碳环化反应,从而导致茚并菲。在9-(3-茚基)蒽中添加苯并炔,产生相应的茚基三萜烯,以及令人惊讶的是,蒽基甲烷桥连菲。已经证明2-芳烃在苯并[4 + 2]环加成中可以作为1,3-二烯。,和的产品已通过X射线晶体学表征。
    DOI:
    10.1039/b703437g
  • 作为产物:
    描述:
    2-溴化茚magnesium1,2-二溴乙烷硼酸三异丙酯盐酸 作用下, 以 四氢呋喃 为溶剂, 反应 3.25h, 以58%的产率得到1H-茚-2-硼酸
    参考文献:
    名称:
    A Suzuki Coupling Based Route to 2,2‘-Bis(2-indenyl)biphenyl Derivatives
    摘要:
    Because of the promising performance in olefin polymerization of 2,2'-bis(2-indenyldiyl)biphenyl zirconium dichloride, we developed a new and broadly applicable route to 2,2'-bis(2-indenyl)biphenyl derivatives. Reaction of the known 2,2'-diiodobiphenyl (26) with the new 2-indenyl boronic acid (23) did not result in the desired 2,2'-bis(2-indenyl)biphenyl (10); instead an isomer thereof, (spiro-1,1-(2,2'-biphenyl)-2-(2-indenyl)indane) (27), was obtained. It was found that compound 10 could be made via a palladium-catalyzed reaction of 2,2-biphenyldiboronic acid (31) with 2-bromoindene (21) under standard Suzuki reaction conditions. However, the yield of this reaction was low at low palladium catalyst loadings, due to a competitive hydrolysis reaction of 2,2-biphenyldiboronic acid (31). HTE techniques were used to find an economically viable protocol. Thus, use of the commercially available 1.0 molar solution of (n-BU)(4)NOH in methanol with cosolvent toluene led to precipitation of the pure product in a fast and clean reaction, using only 0.7 mol % (0.35 mol % per C-C) of the expensive palladium catalyst.
    DOI:
    10.1021/jo016040i
点击查看最新优质反应信息

文献信息

  • Use of “Homeopathic” Ligand-Free Palladium as Catalyst for Aryl-Aryl Coupling Reactions
    作者:Asaf Alimardanov、Lizette Schmieder-van de Vondervoort、André H. M. de Vries、Johannes G. de Vries
    DOI:10.1002/adsc.200404210
    日期:2004.12
    We have previously shown that the use of ligand-free palladium employing Pd(OAc)2 as catalyst precursor in the Heck reaction of aryl bromides is possible if low catalyst loadings, typically between 0.01–0.1 mol % are used. We have now tested this phenomenon, which we have dubbed “homeopathic” palladium, in biaryl formation using the Suzuki, the Negishi and the Kumada cross-coupling reactions. The Suzuki
    先前我们已经表明,如果使用低催化剂负载量(通常在0.01-0.1 mol%之间),则可以在芳基溴的Heck反应中使用以Pd(OAc)2为催化剂前体的无配体钯。现在,我们使用铃木,根岸和熊田交叉偶联反应在联芳基形成中测试了这种被称为“顺势疗法”钯的现象。使用0.02–0.05 mol%的Pd(OAc)2可以进行活化和失活的芳基溴化物的Suzuki反应。在该反应中,活化的底物的转换频率高达30,000。如果存在强吸电子取代基,甚至芳基氯化物也可能发生反应。Negishi与各种芳基卤化锌的偶联可能在含有吸电子取代基的芳基溴化物上进行。熊田反应仅在“顺势疗法”条件下产生低产率的产物。
  • 2-Aryl-indenylphosphine ligands: design, synthesis and application in Pd-catalyzed Suzuki–Miyaura coupling reactions
    作者:Ze-Yu Lian、Jia Yuan、Meng-Qi Yan、Yan Liu、Xue Luo、Qing-Guo Wu、Sheng-Hua Liu、Jian Chen、Xiao-Lei Zhu、Guang-Ao Yu
    DOI:10.1039/c6ob01675h
    日期:——
    A focused library of phosphine ligands was constructed for structural optimization. The catalyst can be used to perform the Suzuki–Miyaura cross-coupling reaction of aryl and heteroaryl chlorides.
    构建了膦配体的聚焦库以进行结构优化。该催化剂可用于进行芳基和杂芳基氯化物的Suzuki-Miyaura交叉偶联反应。
  • An active catalytic system for Suzuki–Miyaura cross-coupling reactions using low levels of palladium loading
    作者:Meng-Qi Yan、Jia Yuan、Fang Lan、Si-Hao Zeng、Meng-Yue Gao、Sheng-Hua Liu、Jian Chen、Guang-Ao Yu
    DOI:10.1039/c7ob00178a
    日期:——
    An easily available Pd(OAc)2/(2-(anthracen-9-yl)-1H-inden-3-yl) dicyclohexylphosphine/toluene/iPrOH/water catalytic system was developed, which shows high catalytic activity in the Suzuki–Miyaura cross-coupling reactions of a diverse array of aryl and heteroaryl chlorides with Pd loadings down to 0.01 mol%.
    容易获得的Pd(OAC)2 /(2-(蒽-9-基)-1- ħ茚-3-基)二环己基膦/甲苯/我异丙醇/水催化体系被开发,其显示高的催化在铃木活动–Miyaura的各种芳基和杂芳基氯化物的交叉偶联反应,其Pd含量低至0.01 mol%。
  • Copper-Catalyzed Cross-Coupling of Vinyliodonium Salts and Zinc-Based Silicon Nucleophiles
    作者:Liangliang Zhang、Martin Oestreich
    DOI:10.1021/acs.orglett.8b03714
    日期:2018.12.21
    A silylation of vinyliodonium salts using zinc-based silicon reagents as nucleophiles is reported. This cross-coupling is catalyzed by copper, and vinylsilanes are obtained in high yield likely following a Cu(I)/Cu(III) reaction mechanism. The procedure is operationally simple, neither air- nor moisture-sensitive, and tolerant of a range of functional groups. The new method is an addition to the still
    报道了使用锌基硅试剂作为亲核试剂使乙烯基碘鎓盐甲硅烷基化。该交叉偶联由铜催化,并且可能遵循Cu(I)/ Cu(III)反应机理以高收率获得乙烯基硅烷。该程序操作简单,对空气和湿度均不敏感,并且可以耐受多种官能团。该新方法是对过渡金属催化的乙烯基C(sp 2)-Si交叉偶联反应数量仍然有限的补充。
  • [EN] THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE THIAZOLE ET LEURS PROCÉDÉS D'UTILISATION
    申请人:SCHERING CORP
    公开号:WO2009058728A1
    公开(公告)日:2009-05-07
    The present invention relates to novel Thiazole Derivatives, compositions comprising the Thiazole Derivatives, and methods for using the Thiazole Derivatives for treating or preventing a proliferative disorder, an anti-proliferative disorder, inflammation, arthritis, a central nervous system disorder, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral infection, a fungal infection, or a disorder related to the activity of a protein kinase.
    本发明涉及新型噻唑衍生物,包含该噻唑衍生物的组合物,以及使用该噻唑衍生物治疗或预防增生性疾病、抗增生性疾病、炎症、关节炎、中枢神经系统疾病、心血管疾病、脱发、神经疾病、缺血性损伤、病毒感染、真菌感染或与蛋白激酶活性相关的疾病的方法。
查看更多

同类化合物

马来酸二甲茚定 螺[茚-1,4’-哌啶]盐酸盐 螺[茚-1,4-哌啶] 螺[1H-茚-1,4-哌啶]-3-羧酸盐酸盐 螺[1H-茚-1,4-哌啶]-1,3-二羧酸,1,1-二甲基乙酯 螺[1,3-二氧戊环-2,1'-茚] 茚洛秦 茚旦醇 茚并[2,1-a]茚 茚屈林 茚-2,3-二羧酸 苯酚,2-(1H-茚-3-基)- 苯茚达明酒石酸盐 苯茚胺 苯基亚甲基双(三环己基磷)二氯化钌 膦,1H-茚-1-基二苯基- 硬树脂 硫化舒林酸 硫化舒林酸 盐酸茚诺洛尔 盐酸茚洛秦 盐酸苯二胺 甲茚 甲基3-氨基-1H-茚-2-羧酸酯 甲基3-氨基-1-氰基-1-苯基-1H-茚-2-羧酸酯 甲基1-氧代-2-苯基-1H-茚-3-基碳酸酯 氨甲酸,[(1S)-1-甲基-2-(硝基氧代)乙基]-,1,1-二甲基乙基酯(9CI) 异苯茚达明 尿苷,2'-脱氧-5-(2-羟基乙基)-,3',5'-二(4-甲基苯酸酯)(9CI) 外消旋-N-去甲基二甲茚定 四氢荧蒽 四-1H-茚-1-ylstannane 吡喃达明盐酸盐 吡喃达明 叔-丁基6-甲基螺[茚并-1,4-哌啶]-1-甲酸基酯 叔-丁基6-氯螺[茚并-1,4-哌啶]-1-甲酸基酯 亚乙基二(4,5,6,7-四氢-1-茚基)二甲基锆(IV) 二茚并[1,2-b:2,1-e]吡啶-10,12-二酮,5,11-二氢-5-甲基- 二甲茚定 二甲基[二(2-甲基-1H-茚-1-基)]硅烷 二甲基-(2-吗啉-4-基-茚-1-亚基甲基)-胺 二环己基[2-(2,4,6-三甲基苯基)-1H-茚-3-基]膦 二-1H-茚-1-基-二甲基硅烷 三(异丙氧基)膦(3-苯基-1H-茚-1-基)[1,3-双(2,4,6-三甲基苯基)-4,5-二氢咪唑-2-基]钌(II)二氯化物 三乙基-茚-1-基-硅烷 rac-乙烯双(1-茚基)二氯化锆 [4-(4-叔丁基苯基)-2-异丙基-1H-茚-1-基][4-(4-叔丁基苯基)-2-甲基-1H-茚-1-基]二甲基硅烷 [(1Z)-5-氟-2-甲基-1-(3-噻吩基亚甲基)-1H-茚-3-基]乙酸 N,N-二甲基-3-[(1S)-1-(2-吡啶基)乙基]-1H-茚满-2-乙胺马来酸酯